# A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer

> **NCT01964170** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 234 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** degarelix
- **DRUG:** Goserelin

## Key facts

- **NCT ID:** NCT01964170
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-13
- **Primary completion:** 2015-06-05
- **Final completion:** 2016-08-08
- **Target enrollment:** 234 (ACTUAL)
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01964170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01964170, "A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01964170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*